TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.930
+0.070 (1.81%)
At close: Mar 20, 2026, 4:00 PM EDT
3.940
+0.010 (0.25%)
After-hours: Mar 20, 2026, 7:13 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $240.93 million as of March 20, 2026. Its market cap has increased by 39.60% in one year.
Market Cap
240.93M
Enterprise Value
254.94M
1-Year Change
39.60%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $240.93M, a decrease of -26.71%. That is a compound annual growth rate of -5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 240.93M | -30.92% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senseonics Holdings | 270.67M |
| ClearPoint Neuro | 267.86M |
| RxSight | 265.76M |
| BrainsWay | 258.10M |
| enVVeno Medical | 233.70M |
| CVRx, Inc. | 228.65M |
| 908 Devices | 228.39M |
| Quanterix | 200.90M |